Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

New/Old: TELSTAR and DEXA-ARDS

New/Old: TELSTAR and DEXA-ARDS

FromICU Ed and Todd-Cast


New/Old: TELSTAR and DEXA-ARDS

FromICU Ed and Todd-Cast

ratings:
Length:
44 minutes
Released:
Mar 13, 2023
Format:
Podcast episode

Description

Episode 6! In this episode we discuss 1) "Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest" by Ruijter et al published NEJM 2022 and 2) "Dexamethasone treatment for the acute respiratory distress synrome" by Villar et al published Lancet Respiratory Medicine 2020. This episode is a little bit longer than normal because we also extended our conversation of steroids in ARDS to the LaSRS (steroids in late ARDS) and Meduri 2007 methylprednisolone in early ARDS studies!TELSTAR: https://pubmed.ncbi.nlm.nih.gov/35196426/DEXA-ARDS: https://pubmed.ncbi.nlm.nih.gov/32043986/Steroids in ARDS CHEST Point: https://pubmed.ncbi.nlm.nih.gov/33422200/and Counterpoint: https://pubmed.ncbi.nlm.nih.gov/33422201/Be sure to follow us on the social @icucast for the associated figures, comments, and other content not available in the audio format! Email us at icuedandtoddcast@gmail.com with any questions or suggestions! Thank you Mike Gannon for the intro and exit music!
Released:
Mar 13, 2023
Format:
Podcast episode

Titles in the series (40)

Two critical care guys walk into a recording studio and breakdown intensive care trials both old and new! We'll also do deep dives on specific topics important to practicing intensive care medicine and have special guests talking about their area of expertise! This podcast is made for educational purposes. The content provided in this podcast, and in any linked materials, is not intended and should not be construed as medical advice and should not be used to diagnose or treat any medical condition. We try to stay away from opinions but all opinions represent our own and not of any entity we work for. Please keep this in mind as you enjoy the podcast!